ViewRay to Present at the 2019 Piper Jaffray 31st Annual Healthcare Conference
ViewRay, Inc. today announced that the Company will participate in the 2019 Piper Jaffray 31st Annual Healthcare Conference in New York, New York.
Leveraging on-table MR soft tissue imaging, MRIdian allows oncologists to visualize, adapt and target using diagnostic-quality anatomical detail that’s simply unavailable with conventional IGRT technologies.
Combining the latest innovations in precision radiation delivery, ground-breaking MR image guidance, and on-table adaptive therapy, MRIdian represents a new paradigm in radiation oncology.
ViewRay to Present at the 2019 Piper Jaffray 31st Annual Healthcare Conference
ViewRay, Inc. today announced that the Company will participate in the 2019 Piper Jaffray 31st Annual Healthcare Conference in New York, New York.
ViewRay Reports Third Quarter 2019 Results
ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the third quarter ended September 30, 2019.
Penn State Health Enters into Master Purchase Agreement with ViewRay for MRIdian® Systems
Immediate order of one system with ability to purchase an additional three systems by Penn State Health.
A new kind of medical technology company—ViewRay® Inc. designs, manufactures and markets MRIdian, the world’s first MRI-Guided radiation therapy system to image and treat cancer patients simultaneously.
Contact Us Today To Learn More Contact
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy